Why the study?
What is the prevalence of persistent lipid abnormalities and goal attainment in Portuguese hypertensive patients treated with statins?
What is the prevalence of persistent lipid abnormalities and goal attainment in Portuguese hypertensive patients treated with statins?
A significant proportion of Portuguese hypertensive patients on statins fail to achieve blood pressure and lipid targets, highlighting a substantial gap in real-world guideline implementation and a need for treatment optimization.
Answers are grounded in this paper and cite their sources.
Indicates gaps in target attainment among statin-treated hypertensives; leaves open whether optimized strategies improve control.
This study aimed to assess the treatment patterns and prevalence of persistent lipid abnormalities in Portuguese hypertensive patients concomitantly treated with statins. Only 25% of the 656 hypertensive patients achieved the blood pressure goals in use during the study period. Similarly, only 33% and 37% attained the recommended levels of total cholesterol<4.5 mmol/L and LDL cholesterol<2.5 mmol/L, respectively. Relatively low doses of medium potency statins were the mainstay of therapy. There seems to be considerable room for improvement through the use of more potent statins, dose up-titration, and/or addition of other lipid-modifying therapies.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: